Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Nitrosalicylate Reduction, Amylase

FDA product code CJD · 1 cleared devices

Class 2 Clinical Chemistry
Regulation
21 CFR 862.1070
Review panel
CH
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
1996-06-28 – 1996-06-28
↑